Sandoz to sell Adderall in the US
This article was originally published in Scrip
Executive Summary
Shire has agreed to supply an authorized generic version of Adderall XR to Sandoz, the generic arm of Novartis. The amphetamine-based hyperactivity drug went off patent in 2009, but still generated sales of $81m for Shire in the third quarter of this year.